Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Amadea Britton"'
Autor:
Cynthia Porter, Zoe L. Lyski, Jennifer L. Uhrlaub, Katherine D. Ellingson, Zuha Jeddy, Lisa Gwynn, Patrick Rivers, Ryan Sprissler, Kurt T. Hegmann, Melissa M. Coughlin, Ashley L. Fowlkes, James Hollister, Lindsay LeClair, Josephine Mak, Shawn C. Beitel, Sammantha Fuller, Pearl Q. Zheng, Molly Vaughan, Ramona P. Rai, Lauren Grant, Gabriella Newes-Adeyi, Young M. Yoo, Lauren Olsho, Jefferey L. Burgess, Alberto J. Caban-Martinez, Sarang K. Yoon, Amadea Britton, Manjusha Gaglani, Andrew L. Phillips, Matthew S. Thiese, Melissa Briggs Hagen, Jefferson M. Jones, Karen Lutrick
Publikováno v:
Diseases, Vol 12, Iss 8, p 171 (2024)
Hybrid immunity, as a result of infection and vaccination to SARS-CoV-2, has been well studied in adults but limited evidence is available in children. We evaluated the antibody responses to primary SARS-CoV-2 infection among vaccinated and unvaccina
Externí odkaz:
https://doaj.org/article/bc49582dbdce4392a042934393234417
Autor:
Jennifer L. Farrar, Lana Childs, Mahamoudou Ouattara, Fahmina Akhter, Amadea Britton, Tamara Pilishvili, Miwako Kobayashi
Publikováno v:
Pathogens, Vol 12, Iss 5, p 732 (2023)
New pneumococcal conjugate vaccines (PCVs), 15- and 20-valent (PCV15 and PCV20), have been licensed for use among U.S. adults based on safety and immunogenicity data compared with the previously recommended 13-valent PCV (PCV13) and 23-valent pneumoc
Externí odkaz:
https://doaj.org/article/44dc6f57f9b444ba980437fedb196d39
Autor:
Sarah E. Smith-Jeffcoat, Sadia Sleweon, Mitsuki Koh, George M. Khalil, Marcos C. Schechter, Paulina A. Rebolledo, Vyjayanti Kasinathan, Adam Hoffman, Rebecca Rossetti, Talya Shragai, Kevin O'Laughlin, Catherine C. Espinosa, Bettina Bankamp, Michael D. Bowen, Ashley Paulick, Amy S. Gargis, Jennifer M. Folster, Juliana da Silva, Caitlin Biedron, Rebekah J. Stewart, Yun F. Wang, Hannah L. Kirking, Jacqueline E. Tate, CDC COVID-19 Emergency Response GA-10 Field, Halie K. Miller, AdeSubomi O. Adeyemo, Anne C. Moorman, Brenda L. Bauman, Kahaliah Joseph, Michelle O'Hegarty, Nazia Kamal, Mila Cohen, Amadea Britton, Courtney T. Callahan, Jamila Fonseka, Elfriede Agyemang, Miriam J. Lawson, Molly Deutsch-Feldman, Tejpratap S. P. Tiwari, Samira Sami, Hong Tao
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
We aimed to describe frequency of COVID-19 exposure risk factors among patients presenting for medical care at an urban, public hospital serving mostly uninsured/Medicare/Medicaid clients and risk factors associated with SARS-CoV-2 infection. Consent
Externí odkaz:
https://doaj.org/article/e30e3184320e45c9ae724a8093f5ee35
Autor:
Katherine E. Fleming-Dutra, Allison Avrich Ciesla, Lauren E. Roper, Zachary R. Smith, Joseph D. Miller, Emma K. Accorsi, Jennifer R. Verani, Nong Shang, Gordana Derado, Ryan E. Wiegand, Tamara Pilishvili, Amadea Britton, Ruth Link-Gelles
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 72:177-182
Autor:
Ruth Link-Gelles, Allison Avrich Ciesla, Lauren E. Roper, Heather M. Scobie, Akilah R. Ali, Joseph D. Miller, Ryan E. Wiegand, Emma K. Accorsi, Jennifer R. Verani, Nong Shang, Gordana Derado, Amadea Britton, Zachary R. Smith, Katherine E. Fleming-Dutra
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 72:119-124
Autor:
Emma K, Accorsi, Sopio, Chochua, Heidi L, Moline, Matt, Hall, Adam L, Hersh, Samir S, Shah, Amadea, Britton, Paulina A, Hawkins, Wei, Xing, Jennifer, Onukwube Okaro, Lindsay, Zielinski, Lesley, McGee, Stephanie, Schrag, Adam L, Cohen
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:1169-1173
In May 2022, CDC learned of three children in California hospitalized concurrently for brain abscess, epidural empyema, or subdural empyema caused by Streptococcus intermedius. Discussions with clinicians in multiple states raised concerns about a po
Autor:
Allison Avrich Ciesla, Ryan E Wiegand, Zachary R Smith, Amadea Britton, Katherine E Fleming-Dutra, Joseph Miller, Emma K Accorsi, Jennifer R Verani, Nong Shang, Gordana Derado, Tamara Pilishvili, Ruth Link-Gelles
Publikováno v:
Open Forum Infectious Diseases. 10
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) BA.2/BA.2.12.1 and BA.4/BA.5 subvariants have mutations associated with increased capacity to evade immunity when compared with prior variants. We evaluated mRNA monovalent b
Autor:
Chelsea S Lutz, Rachel M Hartman, Deionna E Vigil, Amadea Britton, Amanda B Burrage, Angela P Campbell, Ryan M Close, Christine Desnoyers, Jennifer Dobson, Starla Garcia, Natasha Halasa, Elvira Honie, Miwako Kobayashi, Meredith McMorrow, Heba H Mostafa, Dennie Parker, Kyle Pohl, Mila M Prill, Jennifer Richards, Kristen C Roessler, Catherine G Sutcliffe, Kim Taylor, Amy Swango-Wilson, Puthiery Va, Jennifer R Verani, Rosalyn J Singleton, Laura L Hammitt
Publikováno v:
Open Forum Infectious Diseases. 10
Background Despite the disproportionate morbidity and mortality experienced by American Indian and Alaska Native (AI/AN) persons during the coronavirus disease 2019 (COVID-19) pandemic, few studies have reported vaccine effectiveness (VE) estimates a
Autor:
Miwako Kobayashi, Jennifer L. Farrar, Ryan Gierke, Amadea Britton, Lana Childs, Andrew J. Leidner, Doug Campos-Outcalt, Rebecca L. Morgan, Sarah S. Long, H. Keipp Talbot, Katherine A. Poehling, Tamara Pilishvili
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:109-117
In 2021, 20-valent pneumococcal conjugate vaccine (PCV) (PCV20) (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.) and 15-valent PCV (PCV15) (Merck SharpDohme Corp.) were licensed by the Food and Drug Administration for adults aged ≥18 years,
Autor:
Ruth Link-Gelles, Allison Avrich Ciesla, Katherine E. Fleming-Dutra, Zachary R. Smith, Amadea Britton, Ryan E. Wiegand, Joseph D. Miller, Emma K. Accorsi, Stephanie J. Schrag, Jennifer R. Verani, Nong Shang, Gordana Derado, Tamara Pilishvili
Publikováno v:
MMWR. Morbidity and mortality weekly report. 71(48)
On September 1, 2022, bivalent COVID-19 mRNA vaccines, composed of components from the SARS-CoV-2 ancestral and Omicron BA.4/BA.5 strains, were recommended by the Advisory Committee on Immunization Practices (ACIP) to address reduced effectiveness of